HANALL BIOPHARMA
LIVE

Serial Number

79388966

Owner

Hanall Biopharma Co., Ltd.

Attorney

John M. Kim

Filing Date

Nov 16, 2023

Add to watchlist:

No watchlists yet
View on USPTO

HANALL BIOPHARMA Trademark

Serial Number: 79388966 • Registration: 7617111

HANALL BIOPHARMA is a trademark filed by Hanall Biopharma Co., Ltd. on November 16, 2023. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

Hanall Biopharma Co., Ltd. (3 trademarks)

43, Sangseodang 1-gil, Daedeok-gu

Entity Type: 03

Trademark Details

Filing Date

November 16, 2023

Registration Date

December 24, 2024

Published for Opposition

October 22, 2024

Goods & Services

Advice in the field of construction drafting; engineering surveying; rental of scientific equipment; research relating to mechanical engineering; meteorological observation for others; services for assessing the safety of agricultural chemicals; cosmetology research services; industrial design; pharmaceutical drug development services; pharmaceutical product evaluation; pharmaceutical research services; scientific research services in the fields of medicine, health and pharmacology; medical research; product safety testing; textile design; research in the field of computer software development; marine, aerial and land surveying; oceanography research; chemical analysis; scientific research in the nature of providing environmental impact surveys

Price comparison services; distribution of samples; wholesale store services featuring nutraceuticals for use as a dietary supplement; retail store services featuring nutraceuticals for use as a dietary supplement; wholesale store services featuring medical apparatus; retail store services featuring medical apparatus; wholesale store services featuring medical apparatus and instruments; retail store services featuring medical apparatus and instruments; wholesale store services featuring pharmaceuticals; retail store services featuring pharmaceuticals; wholesale store services featuring medicines for human purposes; retail store services featuring medicines for human purposes; wholesale store services featuring fruit-based dietary supplements via the internet; retail store services featuring fruit-based dietary supplements via the internet; wholesale store services featuring make-up preparations via the internet; retail store services featuring make-up preparations via the internet; wholesale store services featuring nutraceuticals via the internet; retail store services featuring nutraceuticals via the internet; wholesale store services featuring make-up preparations; retail store services featuring make-up preparations

Reagents for use in diagnostic testing of Hepatitis B surface antibody for medical purposes and pharmaceutical agents affecting sensory organs; thyroid and para-thyroid hormone preparations; tonics, namely, medicines for autoimmune disease, ocular disease, ear disease, neurodegenerative disease, and cancer; anthelmintics; antiemetics; local anaesthetics; anti-cough drops; pituitary hormone preparations; pharmaceutical preparations for treating diabetes; pharmaceutical agents affecting metabolism; veterinary preparations for the treatment of autoimmune disease, ocular disease, ear disease, neurodegenerative disease, and cancer; prescription synthetic narcotics; anaesthetics; pharmaceutical agents affecting peripheral nervous system; pharmaceutical preparations for immunity improvement; pharmaceutical agents for treating physically caused lesions; pharmaceuticals for the treatment of erectile dysfunction; vesicants for wart removal; vaccines; adrenal hormone preparations; pharmaceutical preparations for the treatment of urogenital organs; vitamin preparations; pharmaceutical products for the treatment of bone diseases; crude medicines for the treatment of autoimmune disease, ocular disease, ear disease, neurodegenerative disease, and cancer; anti-inflammatory and antipyretic preparations; pharmaceutical agents affecting digestive organs; biological preparations for veterinary purposes for the treatment of autoimmune disease, ocular disease, ear disease, neurodegenerative disease, and cancer; chemical preparations for veterinary purposes for the treatment of autoimmune disease, ocular disease, ear disease, neurodegenerative disease, and cancer; cardiovascular pharmaceutical preparations; chemico-pharmaceutical preparations for the treatment of autoimmune disease, ocular disease, ear disease, neurodegenerative disease, and cancer; pharmaceutical agents for epidermis; medicines for the treatment of gastrointestinal diseases; diagnostic preparations for medical or veterinary purposes; drugs for medical purposes for the treatment of autoimmune disease, ocular disease, ear disease, neurodegenerative disease, and cancer; medical diagnostic reagents; diuretics; medicines for human purposes for the treatment of autoimmune disease, ocular disease, ear disease, neurodegenerative disease, and cancer; antacids; haematogen; pharmaceutical preparations for the treatment of tumours; pharmaceutical preparations acting on the central nervous system; analgesics; medical preparations for slimming purposes; medicines for dental purposes; dermatological pharmaceutical products; antibiotics; anti-cancer preparations; blood solvents for medical or veterinary purposes; pharmaceutical preparations for the treatment of respiratory organs; preparations for the treatment of burns; chemotherapeutics

Filing History

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Jul 26, 2025 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jul 7, 2025 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Jul 7, 2025 OPNR
FINAL DECISION TRANSACTION PROCESSED BY IB
Jul 5, 2025 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jun 15, 2025 FICS
FINAL DISPOSITION PROCESSED
Jun 14, 2025 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Mar 25, 2025 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Dec 24, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Dec 24, 2024 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 22, 2024 NPUB
PUBLISHED FOR OPPOSITION
Oct 22, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 2, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 12, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 6, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 6, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 6, 2024 TROA
REFUSAL PROCESSED BY IB
Aug 4, 2024 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jul 16, 2024 RFCS
REFUSAL PROCESSED BY MPU
Jul 16, 2024 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jun 25, 2024 RFCR
NON-FINAL ACTION WRITTEN
Jun 24, 2024 CNRT
ASSIGNED TO EXAMINER
Jun 21, 2024 DOCK
APPLICATION FILING RECEIPT MAILED
Feb 16, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 12, 2024 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Feb 9, 2024 REPR